No video

How to talk to patients about JAK inhibitor safety | Victoria Ruffing

  Рет қаралды 1,912

Medicine Matters rheumatology

Medicine Matters rheumatology

Күн бұрын

Following the results of the ORAL Surveillance trial, which demonstrated increased rates of adverse events in people taking JAK inhibitors, Victoria Ruffing provides guidance on how to talk to patients about the risks associated with these medications (6:42).
View more on Medicine Matters rheumatology: bit.ly/2U6Vxhi

Пікірлер
JAK inhibitors in Psoriasis and PsA
22:46
RheumNow
Рет қаралды 834
JAK Inhibitors in Rheumatoid Arthritis
26:03
PeerView CME
Рет қаралды 10 М.
🩷🩵VS👿
00:38
ISSEI / いっせい
Рет қаралды 23 МЛН
Magic trick 🪄😁
00:13
Andrey Grechka
Рет қаралды 49 МЛН
Schoolboy Runaway в реальной жизни🤣@onLI_gAmeS
00:31
МишАня
Рет қаралды 3,4 МЛН
艾莎撒娇得到王子的原谅#艾莎
00:24
在逃的公主
Рет қаралды 52 МЛН
02/13/24 "JAK" of All Trades, Master of Atopic Dermatitis?
1:00:04
UW AI Teaching Series
Рет қаралды 563
JAK inhibitors for alopecia areata - challenges and successes
11:47
prof. Lidia Rudnicka
Рет қаралды 15 М.
Safety concerns rise over the use of biologic drugs
7:28
CBS News
Рет қаралды 4 М.
The 7 SURPRISING Ways To Heal Trauma WITHOUT MEDICATION | Dr. Bessel Van Der Kolk
1:31:28
EULAR 2023 Symposium: The “Case” for JAK Inhibitors
1:09:08
The Immune-Mediated Inflammatory Disease Forum
Рет қаралды 824
JAK inhibitors for IBD
26:43
Charlie Lees
Рет қаралды 6 М.
JAK Inhibitor Treatment for Alopecia Areata: Understanding Side Effects and Monitoring
58:55
National Alopecia Areata Foundation
Рет қаралды 8 М.
🩷🩵VS👿
00:38
ISSEI / いっせい
Рет қаралды 23 МЛН